# Elimination of Hepatitis C Virus Among Users of Substances

> **NCT05503979** · — · UNKNOWN · sponsor: **Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran** · enrollment: 1000 (estimated)

## Conditions studied

- Hepatitis C in Substance Users

## Interventions

- **DRUG:** Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]

## Key facts

- **NCT ID:** NCT05503979
- **Lead sponsor:** Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-15
- **Primary completion:** 2023-08-15
- **Final completion:** 2024-05-15
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05503979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05503979, "Elimination of Hepatitis C Virus Among Users of Substances". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05503979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*